ID   NCC-MFS1-C1
AC   CVCL_VT41
SY   NCCMFS1C1
DR   DepMap; ACH-002794
DR   Wikidata; Q95992533
RX   PubMed=30737712;
WW   https://en.cellline.jp/product/ncc-mfs1-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 78 hours (PubMed=30737712).
CC   Omics: Deep proteome analysis.
CC   Derived from site: In situ; Forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
ST   Source(s): PubMed=30737712
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 30-01-24; Version: 8
//
RX   PubMed=30737712; DOI=10.1007/s13577-018-00233-1;
RA   Kito F., Oyama R., Sakumoto M., Shiozawa K., Qiao Z.-W., Toki S.,
RA   Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of a novel cell line, NCC-MFS1-C1,
RT   derived from a patient with myxofibrosarcoma.";
RL   Hum. Cell 32:214-222(2019).
//